Considerations in establishing bioequivalence of inhaled compounds

I Mayers, M Bhutani - Expert Opinion on Drug Delivery, 2018 - Taylor & Francis
Introduction: Generic inhalers are often perceived as inferior to their branded counterparts;
however, they are safe and effective if they can meet the regulatory requirements. The …
被引用次数：10 相关文章

Considerations in establishing bioequivalence of inhaled compounds

I Mayers, M Bhutani - Expert opinion on drug delivery, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction Generic inhalers are often perceived as inferior to their branded counterparts;
however, they are safe and effective if they can meet the regulatory requirements. The …
[PDF] archive.org

[PDF][PDF] Considerations in establishing bioequivalence of inhaled compounds

I Mayers, M Bhutani - EXPERT OPINION ON DRUG DELIVERY, 2018 - scholar.archive.org
Introduction: Generic inhalers are often perceived as inferior to their branded counterparts;
however, they are safe and effective if they can meet the regulatory requirements. The …

Considerations in establishing bioequivalence of inhaled compounds.

I Mayers, M Bhutani - Expert Opinion on Drug Delivery, 2017 - europepmc.org
Generic inhalers are often perceived as inferior to their branded counterparts; however, they
are safe and effective if they can meet the regulatory requirements. The approach to assess …